Sanlioglu, A. D. Et Al. 2007. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. CANCER GENE THERAPY , vol.14, no.12 , 976-984.

Sanlioglu, A. D., KARACAY, B., KOKSAL, I. T., GRIFFITH, T. S., & Sanlioglu, S., (2007). DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. CANCER GENE THERAPY , vol.14, no.12, 976-984.

Sanlioglu, AHTER Et Al. "DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells," CANCER GENE THERAPY , vol.14, no.12, 976-984, 2007

Sanlioglu, AHTER D. Et Al. "DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells." CANCER GENE THERAPY , vol.14, no.12, pp.976-984, 2007

Sanlioglu, A. D. Et Al. (2007) . "DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells." CANCER GENE THERAPY , vol.14, no.12, pp.976-984.

@article{article, author={AHTER DİLŞAD ŞANLIOĞLU Et Al. }, title={DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells}, journal={CANCER GENE THERAPY}, year=2007, pages={976-984} }